<DOC>
	<DOCNO>NCT00674661</DOCNO>
	<brief_summary>Prospective , randomized multicenter study determine safety effectiveness perform corneal collagen cross-linking ( CXL ) use riboflavin UVA light eye ectasia refractive surgery .</brief_summary>
	<brief_title>Corneal Collagen Cross-Linking Ectasia ( CXL )</brief_title>
	<detailed_description>Subjects randomize control group treatment group , control group cross treatment group 3 month visit . Corneal collagen cross-linking perform single treatment . Subjects follow 12 month procedure evaluate long term effect corneal collagen cross-linking .</detailed_description>
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis ectasia refractive surgery Documented ectasia Pentacam topography map BSCVA worse 20/20 Must complete study visit History delay wound heal History corneal melt corneal dystrophy</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ectasia</keyword>
	<keyword>cross-linking</keyword>
	<keyword>crosslinking</keyword>
	<keyword>cornea</keyword>
	<keyword>riboflavin</keyword>
	<keyword>UVA</keyword>
</DOC>